BioSpace News Archive

Drug Development

Biogen to Halt Work on Opicinumab, Steer Focus Toward Parkinson’s Disease

Biogen originally announced the initiation of its Phase II clinical trial, AFFINITY, designed to evaluate opicinumab back in 2017. The drug was being examined as an investigational add-on therapy for patients with relapsing MS.

October 21, 2020
·
3 min read
·
Krystle Vermes
Drug Development

As Others Falter, Sagimet CEO Confident for Success of Experimental NASH Treatment

Finding and developing an effective treatment for nonalcoholic steatohepatitis has, so far, been met with as much futility and frustration as developing a treatment for Alzheimer’s disease. Sagimet Biosciences Chief Executive Officer George Kemble believes his company is on the right path, though.

October 21, 2020
·
3 min read
·
Alex Keown
Drug Development

AstraZeneca Shares Drop Following Report of a COVID-19 Vaccine Study Patient Death in Brazil

Shares of AstraZeneca dropped slightly Wednesday afternoon following reports that a patient participating in the Brazilian arm of the company’s global Phase III study has died.

October 21, 2020
·
3 min read
·
Alex Keown
How to Overcome Mistakes at Work

Follow these steps to rectify mistakes you make at work and learn from the admittedly unfortunate situation. Here are some pointers to overcome mistakes at work.

October 21, 2020
·
2 min read
·
Laura Brothers
Neural Dust: Millimeter-Sized Brain Stimulators

Bolstered by studies in rodents, iota Biosciences advances towards their vision.

October 21, 2020
·
4 min read
·
Simon Spichak
Keytruda Paves the Way for More Effective Classical Hodgkin Lymphoma Treatment

FDA had approved its expanded label for Keytruda. Specifically, the anti-PD-1 therapy’s expanded label was approved for the treatment of relapsed or refractory cHL.

October 21, 2020
·
3 min read
·
Krystle Vermes
Deals

StageBio Expands Its Global Presence With Acquisition of TPL Path Labs

Company extends preclinical and clinical histopathology/molecular pathology solutions to researchers on both sides of the Atlantic

October 21, 2020
·
4 min read
Antiviral Combination Therapies Market: Multiple Antiviral Drugs Prove More Effective in Treatment of COVID-19 than Single Drugs

According to the report, the global antiviral combination therapies market was valued at US$ 40.4 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030.

October 21, 2020
·
5 min read
Artificial Organs Market: Artificial Kidney Segment to Dominate the Global Market

Artificial organs consist of complex medical devices that have active biochemical or mechanical functions such as kidney, liver, lung, pancreas, heart, or neurosensory organs

October 21, 2020
·
5 min read
Automated Compound Storage and Retrieval (ACSR) Market | Increasing Scope of High-throughput Screening and Automated Screening in Drug Discovery Drive Market Growth

With substantial strides in medical technology alongside the deployment of the Internet of Things across the healthcare sector, the infrastructural growth of the developed and developing nations has paved the way for the expansion of the global market for automated compound storage and retrieval.

October 21, 2020
·
5 min read